DUPHAT 2024
What Is It All About?
DUPHAT, the Dubai International Pharmaceutical & Technology Conference & Exhibition, is just around the corner. This event, which originated in 1955 to support local markets, has evolved into a prominent regional educational brand and a global networking hub for pharmaceutical leaders.
With over 960 brands and exhibiting companies participating, this is the largest and most essential event in the MENA region. It is expected to draw over 22,000 visitors from more than 75 countries, featuring insights from 140+ speakers hailing from various nations.
DelveInsight is excited to be part of this event, where we will cover numerous sessions and workshops while networking with industry experts and Key Opinion Leaders to explore business prospects and share knowledge. Our team aims to learn from diverse medical practitioners, scientists, industry pioneers, researchers, and peers in the MENA region. These valuable insights will be integrated into our future market research endeavors.
Don’t miss the chance to connect with the DelveInsight team at DUPHAT 2024, the foremost healthcare event in the MENA region. We eagerly await your participation. Simply reach out to us by completing the form on the right.
Counting Down 9–11 January 2024 | Dubai World Trade Center
Market Research & Analysis
DelveInsight offers comprehensive analysis to Pharma and biotech goliaths about the market trends in the emerging geographies exclusively focused on the MENA region. We help clients to identify untapped and lucrative opportunities to grab. On the same line, DelveInsight strategizes the business decisions of local pharma players to establish themselves in major markets, including the seven major geographies.
Exclusively focused Rare disease analysis
Rare genetic diseases have been shown to express a significant burden globally, with a significant effect on the MENA region. With an exclusive focus on the Rare disease market, DelveInsight highlights primary and secondary reasons- genetic, lifestyle, and environmental- behind the increasing prevalence of Rare diseases in the MENA. Moreover, this gives pharma and biotech players – local and international- an opportunity to expand their regional portfolio and manufacturing units.
Support across the drug value chain
DelveInsight provides consulting services- that give its clients a competitive edge, providing them with support in the therapy development process from the pre-clinical phase until the therapy enters the market. Moreover, consultants at DelveInsight, with their expertise and experience, help companies to keep themselves prepared for the unexpected challenges that bump into the course of the journey.
Business expansion, Partnering & Licensing opportunities
To sustain in this fast-evolving Life Science market, companies in the Life Science vertical – Small, Medium, and Large – need to expand their business, which is why Mergers, Acquisitions, and Partnering opportunities are ordinarily happening. However, the move requires a lot of brainstorming, market analysis, and intense competitive studies, with which DelveInsight possesses the potential to help. With the vast knowledge of the market - Major and Emerging - and a good number of global clients served, DelveInsight helps local companies to get acquainted with international ones and vice versa, thus facilitating business partnering and expansions.
Regulatory guidelines & Pricing Analysis
With the different regulatory bodies in foreign markets - governing drug approvals and clinical trial guidelines – it becomes quite difficult for pharma players to keep themselves abreast of policy changes. DelveInsight helps its clients diligently lay out specific changes that may boost or hinder their product in the market, along with pricing strategies to yield a better investment return.
We welcome you to discuss your business-related concerns, and we can together find the best possible solution to help you proceed further in the healthcare market.
The DUPHAT 2024 conference and exhibition will take place at Dubai World Trade Center, Dubai, from 9–11 January 2024.